198 related articles for article (PubMed ID: 24799057)
1. Extracranial oligometastatic renal cell carcinoma: current management and future directions.
Loh J; Davis ID; Martin JM; Siva S
Future Oncol; 2014 Apr; 10(5):761-74. PubMed ID: 24799057
[TBL] [Abstract][Full Text] [Related]
2. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
3. The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma.
Cheung P; Thibault I; Bjarnason GA
Curr Opin Support Palliat Care; 2014 Sep; 8(3):258-64. PubMed ID: 25090288
[TBL] [Abstract][Full Text] [Related]
4. [Improvements of ablative local treatments modify the management of the oligometastatic disease].
Thariat J; Vignot S; Bensadoun RJ; Mornex F
Cancer Radiother; 2012 Sep; 16(5-6):325-9. PubMed ID: 22784592
[TBL] [Abstract][Full Text] [Related]
5. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
6. New Strategies in Stereotactic Radiotherapy for Oligometastases.
Palma DA; Louie AV; Rodrigues GB
Clin Cancer Res; 2015 Dec; 21(23):5198-204. PubMed ID: 26626571
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
8. New concepts and insights into the role of radiation therapy in extracranial metastatic disease.
Ricardi U; Filippi AR; Franco P
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1145-55. PubMed ID: 24134418
[TBL] [Abstract][Full Text] [Related]
9. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
Hong JC; Salama JK
Cancer Treat Rev; 2017 Jan; 52():22-32. PubMed ID: 27886588
[TBL] [Abstract][Full Text] [Related]
10. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
Harshman LC; Srinivas S
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
[TBL] [Abstract][Full Text] [Related]
11. [Stereotactic body radiation therapy and oligometastases].
Bourgier C; Azria D; Fenoglietto P; Riou O; Almaghrabi MY; Supiot S; Mornex F; Giraud P
Cancer Radiother; 2014; 18(4):337-41. PubMed ID: 24792996
[TBL] [Abstract][Full Text] [Related]
12. Nephrectomy for metastatic renal cell carcinoma and surgery for distant metastases.
Van Poppel H; Baert L
Acta Urol Belg; 1996 May; 64(2):11-7. PubMed ID: 8701800
[TBL] [Abstract][Full Text] [Related]
13. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
Wood CG
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
[TBL] [Abstract][Full Text] [Related]
14. A rationale for the targeted treatment of oligometastases with radiotherapy.
Macdermed DM; Weichselbaum RR; Salama JK
J Surg Oncol; 2008 Sep; 98(3):202-6. PubMed ID: 18618604
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic factors for patients with single brain metastasis treated with stereotactic radiosurgery.
Fernandez-Vicioso E; Suh JH; Kupelian PA; Sohn JW; Barnett GH
Radiat Oncol Investig; 1997; 5(1):31-7. PubMed ID: 9303054
[TBL] [Abstract][Full Text] [Related]
16. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
[TBL] [Abstract][Full Text] [Related]
17. Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.
Thibault I; Al-Omair A; Masucci GL; Masson-Côté L; Lochray F; Korol R; Cheng L; Xu W; Yee A; Fehlings MG; Bjarnason GA; Sahgal A
J Neurosurg Spine; 2014 Nov; 21(5):711-8. PubMed ID: 25170656
[TBL] [Abstract][Full Text] [Related]
18. New systemic treatment options for metastatic renal-cell carcinoma in the era of targeted therapies.
Tan TH; Pranavan G; Haxhimolla HZ; Yip D
Asia Pac J Clin Oncol; 2010 Mar; 6(1):5-18. PubMed ID: 20398033
[TBL] [Abstract][Full Text] [Related]
19. Local treatment of oligometastatic recurrence in patients with resected non-small cell lung cancer.
Yano T; Okamoto T; Haro A; Fukuyama S; Yoshida T; Kohno M; Maehara Y
Lung Cancer; 2013 Dec; 82(3):431-5. PubMed ID: 24113550
[TBL] [Abstract][Full Text] [Related]
20. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
